Lpl Financial LLC Omeros Corp Transaction History

Lpl Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $90,000 - $201,600	-10,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$13.26 - $22.86 $41,689 - $71,871	-3,144 Reduced 23.92%	10,000 $194,000
Q3 2017 Nov 14, 2017	BUY	$19.76 - $24.9 $2,845 - $3,585	144 Added 1.11%	13,144 $284,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,000	13,000 $259,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.